Post Profile






Transgender women lose access to critical hormone treatment due to shortages

Thousands of transgender women nationwide are facing a shortage of injectable estrogen after the manufacturer lost supply of a key ingredient and the Food and Drug Administration has failed to approve a new supplier. Originally, the FDA said the drug would be accessible again come October, but now availability appears to be delayed by another month. Samantha Michaels writes: "The FDA recognizes this is an important drug, and is working with the drug manufacturers so that the drug may return to the market as quickly as possible," Andrea Fischer, a spokeswoman for the agency, told BuzzFeed.
read more

share

Related Posts


Generic Version Of Cancer Drug Doxil Approved By FDA

Health : Medical News Today

The U.S. Food and Drug Administration has just approved a generic version of the cancer drug Doxil (doxorubicin hydrochloride liposome injection). There is currently a serious shortage of the drug Doxil, and the decision by the FDA ...

Transgender Women Are Facing A Devastating Shortage Of Injectable Estrogen

Society & Culture / LGBT : Huffington Post: LGBT

Bamby Salcedo describes the past month of her life in one word: “devastation.” It was late August when the activist and community organizer first learned about the ongoing injectable estrogen shortage in the United States, which has...

Trans Women Are Dealing With a Pharma Nightmare

News / Independent News : Mother Jones

A nationwide shortage of injectable estrogen has left thousands of transgender women without a medication that helps them physically transition—and that health experts have described as lifesaving. Injecting estrogen is one of the m...

HRC Takes Action on Injectable Estrogen Shortage

Issues & Causes / Human Rights : HRC Human Rights Campaign

HRC is deeply concerned about the potential impact of a shortage of injectable estrogen on transgender women and others who utilize the drug. This shortage exist for both Delestrogen and its generic counterpart estradiol valerate. B...

Novo Nordisk Receives FDA Approval For Norditropin® FlexPro® For Growth Hormone Treatment

Health : Medical News Today

Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has approved Norditropin® FlexPro® (somatropin [rDNA origin] injection), a pre-filled injection pen to be used by children and adults with growth hormone disord...

Comments


Copyright © 2016 Regator, LLC